E
Nexalin Technology, Inc. NXL
$1.69 -$0.12-6.63%
Recommendation
Sell
Prev Close
$1.69
Volume
130,721
Avg Vol (90D)
341,496
Market Cap
$22.48M
Dividend & Yield
--
52-Week Range
$0.53 - $4.49
P/E (TTM)
--
EPS (TTM)
-$1.05
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
4/2/2025 - GuruFocus
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
4/2/2025 - Globe Newswire
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3
3/26/2025 - GuruFocus
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3
3/26/2025 - Globe Newswire
Nexalin Technology (NASDAQ:NXL) Raised to "Buy" at Maxim Group
3/24/2025 - Ticker Report
Maxim gets more bullish on Nexalin Technology, upgrades shares
3/24/2025 - The Fly
Nexalin Technology (NASDAQ:NXL) Issues Quarterly Earnings Results
3/16/2025 - Ticker Report
Will Nexalin Technology (NASDAQ:NXL) Spend Its Cash Wisely?
3/14/2025 - Simply Wall St
Nexalin Technology, Inc. (NASDAQ:NXL) VP Carolyn Hamby Shelton Buys 6,000 Shares
3/14/2025 - Ticker Report
Nexalin Technology, Inc. (NASDAQ:NXL) VP Carolyn Hamby Shelton Buys 6,000 Shares
3/14/2025 - MarketBeat
Nexalin Technology, Inc. (NASDAQ:NXL) Short Interest Down 30.0% in February
3/5/2025 - Ticker Report
Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS ) Technology for Opioid and Other Substance Use Disorders
3/3/2025 - Globe Newswire
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD's TBI & PTSD ...
2/28/2025 - GuruFocus
Nexalin Technology announces initiation of patient recruitment in UCSD study
2/28/2025 - The Fly
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD's TBI & PTSD Clinical Study Following IRB Approval
2/28/2025 - Globe Newswire
Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board
2/26/2025 - GuruFocus
Nexalin Technology appoints Wesley Clark to Military, Government Advisory Board
2/26/2025 - The Fly
Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board
2/26/2025 - Globe Newswire
Nexalin Technology's HALO Clarity headset approved for use in trials by UCSD
2/18/2025 - The Fly
Nexalin Technology Announces UCSD IRB Approval for use of HALO Clarity in Clinical Trials for mTBI and PTSD Treatment
2/18/2025 - Globe Newswire
Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition
2/10/2025 - Globe Newswire
Analyzing Nexalin Technology (NASDAQ:NXL) and Nexeon Medsystems (OTCMKTS:NXNN)
2/4/2025 - Ticker Report
Nexalin Technology announces publication of study of DIFS technology
2/3/2025 - The Fly
Nexalin Technology announces publication of study of DIFS technology
2/3/2025 - The Fly
Nexalin's Breakthrough DIFS Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study
2/3/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
$168.70K
EBITDA (TTM)
-$7.74M
EBIT (TTM)
-$7.75M
Net Income (TTM)
-$7.61M
Balance Sheet
Total Assets (Q)
$4.22M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$546.70K
Book Value Per Share (Q)
$0.2763
Cash Flow
Cash from Operations (TTM)
-$3.94M
Cash from Investing (TTM)
-$577.50K
Cash from Financing (TTM)
$4.52M
Net Change in Cash (TTM)
-$5.80K
Filings
Filing Date
Friday, March 14, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Created with Highstock 5.0.142. Dec16. Dec30. Dec13. Jan27. Jan10. Feb24. Feb10. Mar24. Mar$1.00$2.00$4.00$6.00Price as of Apr 04, 2025
Beta
1.06
7-Day Total Return
-17.96%
30-Day Total Return
-35.74%
60-Day Total Return
-43.10%
90-Day Total Return
-55.76%
Year to Date Total Return
-47.35%
1-Year Total Return
-32.13%
2-Year Total Return
118.49%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Jun 12, 2024 - $0.53
52-week High
Dec 04, 2024 - $4.49
Valuation
Market Cap
$22.48M - Nano Cap
Enterprise Value
$19.00M
Price/Sales (TTM)
111.18
Price/Book (Q)
6.12
Dividends and Shares
Shares Outstanding
11.04M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.nexalin.com
Phone Number
832-260-0222
Address
776 Yorktown
Houston, TX 77056
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and... more
NASDAQ 04/04/2025 4:00PM Eastern Quotes delayed
Weiss Ratings